Globe Life (NYSE:GL) Price Target Raised to $208.00

Globe Life (NYSE:GL) had its target price upped by equities research analysts at Morgan Stanley from $181.00 to $208.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 16.18% from the company’s previous close.

Several other research analysts have also recently issued reports on the stock. Keefe, Bruyette & Woods reissued a “moderate buy” rating and set a $168.00 price target on shares of Globe Life in a report on Thursday, March 26th. TD Cowen increased their target price on Globe Life from $199.00 to $215.00 and gave the stock a “buy” rating in a research note on Tuesday, June 23rd. Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. Texas Capital upgraded Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Finally, Piper Sandler raised their target price on Globe Life from $167.00 to $175.00 and gave the company an “overweight” rating in a report on Tuesday, May 26th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $178.89.

Globe Life Stock Performance

Shares of Globe Life stock opened at $179.04 on Monday. The firm has a market capitalization of $13.90 billion, a P/E ratio of 12.32 and a beta of 0.47. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life has a 52 week low of $116.73 and a 52 week high of $182.32. The firm’s 50 day moving average is $161.20 and its two-hundred day moving average is $148.91.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The firm had revenue of $1.56 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the firm earned $3.07 EPS. The company’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. Research analysts forecast that Globe Life will post 15.64 EPS for the current fiscal year.

Insider Transactions at Globe Life

In other Globe Life news, EVP Michael Clay Majors sold 34,000 shares of the stock in a transaction that occurred on Friday, April 24th. The shares were sold at an average price of $153.81, for a total transaction of $5,229,540.00. Following the transaction, the executive vice president owned 53,518 shares of the company’s stock, valued at $8,231,603.58. This trade represents a 38.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO James Matthew Darden sold 4,663 shares of Globe Life stock in a transaction on Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the completion of the transaction, the chief executive officer owned 58,451 shares in the company, valued at $8,994,439.88. The trade was a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 124,187 shares of company stock worth $19,529,414 in the last quarter. 2.11% of the stock is currently owned by corporate insiders.

Institutional Trading of Globe Life

Large investors have recently modified their holdings of the business. Compound Planning Inc. grew its position in shares of Globe Life by 4.3% in the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock worth $275,000 after acquiring an additional 82 shares in the last quarter. Root Financial Partners LLC increased its position in Globe Life by 23.3% in the first quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock worth $61,000 after buying an additional 83 shares during the period. Transcend Capital Advisors LLC lifted its stake in Globe Life by 3.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after buying an additional 84 shares during the last quarter. Natural Investments LLC boosted its holdings in shares of Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after acquiring an additional 87 shares during the period. Finally, Parallel Advisors LLC grew its position in shares of Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after acquiring an additional 87 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.